Cormorant Asset Management, LP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 55 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$670,000
-14.2%
286,2000.0%0.11%
+2.9%
Q2 2015$781,000
-18.6%
286,2000.0%0.10%
-29.7%
Q1 2015$959,000
-11.4%
286,200
-8.3%
0.15%
-11.4%
Q4 2014$1,083,000
-52.2%
312,000
-30.7%
0.17%
-64.2%
Q3 2014$2,266,000
-79.5%
450,400
-43.7%
0.47%
-84.1%
Q2 2014$11,048,000
+107.4%
800,000
+129.9%
2.93%
+139.0%
Q1 2014$5,328,000348,0001.22%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders